Clinical Trials Browser

Phase 3 × Carcinoma, Non-Small-Cell Lung × taxane × Clear all

NCT00112294 2015-12-24

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Phase 3 Completed

755 enrolled 26 charts

Carcinoma, Non-Small-Cell Lung